Medibio Limited (MDBIF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -2.02 Million AUD | 19.68% |
| 2023 | -2.51 Million AUD | 3.83% |
| 2022 | -2.22 Million AUD | -73.32% |
| 2021 | -1.28 Million AUD | 65.23% |
| 2020 | -3.69 Million AUD | 43.91% |
| 2019 | -6.57 Million AUD | 56.07% |
| 2018 | -14.96 Million AUD | -138.29% |
| 2017 | -7.79 Million AUD | 14.07% |
| 2016 | -4.24 Million AUD | -142.73% |
| 2015 | -3.01 Million AUD | -839.82% |
| 2014 | -320.31 Thousand AUD | 64.39% |
| 2013 | -899.61 Thousand AUD | 71.42% |
| 2012 | -3.14 Million AUD | 17.37% |
| 2011 | -3.8 Million AUD | -70.15% |
| 2010 | -2.82 Million AUD | -150.52% |
| 2009 | -893.68 Thousand AUD | 63.48% |
| 2008 | -2.44 Million AUD | -145.42% |
| 2007 | -997.16 Thousand AUD | -2.77% |
| 2006 | -970.33 Thousand AUD | 24.12% |
| 2005 | -1.27 Million AUD | 32.68% |
| 2004 | -1.89 Million AUD | 37.14% |
| 2003 | -3.02 Million AUD | 24.9% |
| 2002 | -4.1 Million AUD | -113.93% |
| 2001 | -1.7 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | 5.27% |
| 2024 Q1 | -513.55 Thousand AUD | -23.42% |
| 2024 Q4 | -977.59 Thousand AUD | 0.0% |
| 2024 Q2 | -1.02 Million AUD | -100.0% |
| 2023 Q3 | -416.09 Thousand AUD | 61.56% |
| 2023 Q1 | -72.09 Thousand AUD | 96.52% |
| 2023 FY | - AUD | 3.83% |
| 2023 Q4 | -1.05 Million AUD | -153.3% |
| 2023 Q2 | -1.08 Million AUD | -1401.66% |
| 2022 Q1 | -189.52 Thousand AUD | 80.94% |
| 2022 Q2 | -1.34 Million AUD | -609.44% |
| 2022 Q3 | -922.42 Thousand AUD | 31.4% |
| 2022 FY | - AUD | -73.32% |
| 2022 Q4 | -2.07 Million AUD | -124.88% |
| 2021 FY | - AUD | 65.23% |
| 2021 Q1 | -304.46 Thousand AUD | 76.16% |
| 2021 Q4 | -994.33 Thousand AUD | -251.21% |
| 2021 Q3 | -283.11 Thousand AUD | 81.57% |
| 2021 Q2 | -1.53 Million AUD | -404.54% |
| 2020 FY | - AUD | 43.91% |
| 2020 Q2 | -3 Million AUD | -162.39% |
| 2020 Q3 | -599.75 Thousand AUD | 80.05% |
| 2020 Q4 | -1.27 Million AUD | -112.91% |
| 2020 Q1 | -1.14 Million AUD | 56.81% |
| 2019 Q3 | -1.03 Million AUD | 47.77% |
| 2019 FY | - AUD | 56.07% |
| 2019 Q1 | -1.99 Million AUD | 61.32% |
| 2019 Q4 | -2.65 Million AUD | -155.07% |
| 2019 Q2 | -1.99 Million AUD | -0.0% |
| 2018 Q2 | -2.41 Million AUD | 0.0% |
| 2018 Q1 | -2.41 Million AUD | 23.95% |
| 2018 FY | - AUD | -138.29% |
| 2018 Q4 | -5.14 Million AUD | 0.0% |
| 2018 Q3 | -5.14 Million AUD | -113.19% |
| 2017 Q3 | -3.17 Million AUD | -325.74% |
| 2017 FY | - AUD | 14.07% |
| 2017 Q4 | -3.17 Million AUD | 0.0% |
| 2017 Q1 | -745.68 Thousand AUD | 62.47% |
| 2017 Q2 | -745.68 Thousand AUD | 0.0% |
| 2016 Q3 | -1.98 Million AUD | -1130.57% |
| 2016 FY | - AUD | -142.73% |
| 2016 Q4 | -1.98 Million AUD | 0.0% |
| 2016 Q1 | -161.47 Thousand AUD | 85.0% |
| 2016 Q2 | -161.47 Thousand AUD | 0.0% |
| 2015 FY | - AUD | -839.82% |
| 2015 Q1 | -477.39 Thousand AUD | -5.69% |
| 2015 Q2 | -477.38 Thousand AUD | 0.0% |
| 2015 Q4 | -1.07 Million AUD | -13.63% |
| 2015 Q3 | -947.57 Thousand AUD | -98.49% |
| 2014 Q4 | -451.67 Thousand AUD | 0.0% |
| 2014 Q2 | 57.79 Thousand AUD | -0.0% |
| 2014 Q3 | -451.67 Thousand AUD | -881.48% |
| 2014 Q1 | 57.79 Thousand AUD | 141.68% |
| 2014 FY | - AUD | 64.39% |
| 2013 Q4 | -138.65 Thousand AUD | 0.0% |
| 2013 Q3 | -138.65 Thousand AUD | 0.0% |
| 2013 FY | - AUD | 71.42% |
| 2012 FY | - AUD | 17.37% |
| 2011 FY | - AUD | -70.15% |
| 2010 FY | - AUD | -150.52% |
| 2009 FY | - AUD | 63.48% |
| 2008 FY | - AUD | -145.42% |
| 2007 FY | - AUD | -2.77% |
| 2006 FY | - AUD | 24.12% |
| 2005 FY | - AUD | 32.68% |
| 2004 FY | - AUD | 37.14% |
| 2003 FY | - AUD | 24.9% |
| 2002 FY | - AUD | -113.93% |
| 2001 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Achiko AG | -8.32 Million USD | 75.692% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | -2.84 Million USD | 28.898% |
| Cannabis Sativa, Inc. | -1.11 Million USD | -81.585% |
| CompuMed, Inc. | 690.19 Thousand USD | 393.227% |
| CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 100.951% |
| Cogstate Limited | 9.89 Million USD | 120.461% |
| CareView Communications, Inc. | -210.04 Thousand USD | -863.54% |
| Craneware plc | 54.26 Million USD | 103.73% |
| Caduceus Software Systems Corp. | -12.29 Million USD | 83.536% |
| Certive Solutions Inc. | -704.66 Thousand USD | -187.205% |
| Drug Free Solution, Inc. | -1.39 Million USD | -45.085% |
| DATATRAK International, Inc. | 2.72 Million USD | 174.172% |
| Strainsforpains, Inc. | -65.61 Thousand USD | -2984.635% |
| Healixa Inc. | -6.32 Million USD | 67.979% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 10.16 Million USD | 119.903% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | -375.649% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | - USD | Infinity% |
| IQ-AI Limited | -370.35 Thousand USD | -446.459% |
| Cannabiz Mobile, Inc. | -750.00 USD | -269743.867% |
| Mednow Inc. | -28.12 Million USD | 92.804% |
| Galileo Life Sciences, Inc. | -270.72 Thousand USD | -647.564% |
| MediXall Group, Inc. | -6.52 Million USD | 68.977% |
| Mitesco, Inc. | -11.96 Million USD | 83.083% |
| MobileSmith, Inc. | -13.83 Million USD | 85.374% |
| NantHealth, Inc. | -38.53 Million USD | 94.748% |
| Net Medical Xpress Solutions, Inc. | -1.69 Million USD | -19.189% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | -12.08 Million USD | 83.256% |
| Patient Access Solutions, Inc. | -12.09 Million USD | 83.272% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | 254.287% |
| PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 2808.188% |
| Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | -16510.547% |
| Renalytix Plc | -28.52 Million USD | 92.904% |
| Revium Recovery Inc. | -678 Thousand USD | -198.5% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | -369.00 USD | -548363.144% |
| Vaso Corporation | 4.19 Million USD | 148.244% |
| Vynleads, Inc. | -235.72 Thousand USD | -758.551% |